The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α
Abstract
Objective. To evaluate the safety and efficacy of a chimeric monoclonal antibody to tumor necrosis factor α (TNFα) in the treatment of patients with rheumatoid arthritis (RA). Methods. Twenty patients with active RA were treated with 20 mg/kg of anti‐TNFα in an open phase I/II trial lasting 8 weeks. Results. The treatment was well tolerated, with no serious adverse events. Significant improvements were seen in the Ritchie Articular Index, which fell from a median of 28 at study entry to a median of 6 by week 6 (P < 0.001), the swollen joint count, which fell from 18 to 5 (P < 0.001) over the same period, and in the other major clinical assessments. Serum C‐reactive protein levels fell from a median of 39.5 mg/liter at study entry to 8 mg/liter at week 6 (P < 0.001), and significant decreases were also seen in serum amyloid A and interleukin‐6 levels. Conclusion. Treatment with anti‐TNFα was safe and well tolerated and resulted in significant clinical and laboratory improvements. These preliminary results support the hypothesis that TNFα is an important regulator in RA, and suggest that it may be a useful new therapeutic target in this disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arnett, F. C., Edworthy, S. M., Bloch, D. A., Mcshane, D. J., Fries, J. F., Cooper, N. S., Healey, L. A., Kaplan, S. R., Liang, M. H., Luthra, H. S., et al. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310302 · Cited by 19,752
THERAPEUTIC CRITERIA IN RHEUMATOID ARTHRITIS
STEINBROCKER, O. (1949) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1949.02900430001001 · Cited by 2,877
Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis.
Keffer, J., Probert, L., Cazlaris, H., Georgopoulos, S., Kaslaris, E., Kioussis, D., & Kollias, G. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04978.x · Cited by 1,660
(1968) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a067150 · Cited by 1,349
Espevik, T., & Nissen-Meyer, J. (1986) · Journal of Immunological Methods · doi:10.1016/0022-1759(86)90322-4 · Cited by 1,243
BRENNAN, F. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90430-3 · Cited by 1,129
Self-citationAnti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis.
Williams, R. O., Feldmann, M., & Maini, R. N. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.20.9784 · Cited by 989
Self-citationExcessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis
Hirano, T., Matsuda, T., Turner, M., Miyasaka, N., Buchan, G., Tang, B., Sato, K., Shimi, M., Maid, R., Feldmann, M., et al. (1988) · European Journal of Immunology · doi:10.1002/eji.1830181122 · Cited by 784
Self-citationFong, Y., Tracey, K. J., Moldawer, L. L., Hesse, D. G., Manogue, K. B., Kenney, J. S., Lee, A. T., Kuo, G. C., Allison, A. C., & Lowry, S. F. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.5.1627 · Cited by 641
LONG-TERM OUTCOME OF TREATING RHEUMATOID ARTHRITIS: RESULTS AFTER 20 YEARS
Scott, D. L., Coulton, B. L., Symmons, D. P. M., & Popert, A. J. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91672-2 · Cited by 594
Chu, C. Q., Field, M., Feldmann, M., & Maini, R. N. (1991) · Arthritis & Rheumatism · doi:10.1002/art.1780340908 · Cited by 578
Self-citationGuerne, P. A., Zuraw, B. L., Vaughan, J. H., Carson, D. A., & Lotz, M. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113921 · Cited by 513
KIRWAN, J. R., & REEBACK, J. S. (1986) · Rheumatology · doi:10.1093/rheumatology/25.2.206 · Cited by 488
Evidence that tumor necrosis factor has an important role in antibacterial resistance.
Havell, E. A. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.9.2894 · Cited by 405
TNFα—A PIVOTAL ROLE IN RHEUMATOID ARTHRITIS?
BRENNAN, F. M., MAINI, R. N., & FELDMANN, M. (1992) · Rheumatology · doi:10.1093/rheumatology/31.5.293 · Cited by 386
Self-citationBuchan, G. S., Barrett, K., Turner, M., Chantry, D., Maini, R. N., & Feldmann, M. (1988) · PubMed Central · Cited by 332
Self-citationPincus, T., & Callahan, L. F. (1986) · PubMed · Cited by 321
Humanised monoclonal antibody therapy for rheumatoid arthritis
Isaacs, J. D., Hale, G., Cobbold, S. P., Waldmann, H., Watts, R. A., Hazleman, B. L., & Keogan, M. T. (1992) · The Lancet · doi:10.1016/0140-6736(92)92294-p · Cited by 308
Haworth, C., Brennan, F. M., Chantry, D., Turner, M., Maini, R. N., & Feldmann, M. (1991) · European Journal of Immunology · doi:10.1002/eji.1830211039 · Cited by 299
Self-citationPaulus, H. E., Egger, M. J., Ward, J. R., & James Williams, H. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330403 · Cited by 285
Brennan, F. M., Zachariae, C. O. C., Chantry, D., Larsen, C. G., Turner, M., Maini, R. N., Matsushima, K., & Feldmann, M. (1990) · European Journal of Immunology · doi:10.1002/eji.1830200938 · Cited by 282
Self-citationTreatment of rheumatoid arthritis with an anti‐CD4 monoclonal antibody
Horneff, G., Burmester, G. R., Emmrich, F., & Kalden, J. R. (1991) · Arthritis & Rheumatism · doi:10.1002/art.1780340202 · Cited by 275
A simplified twenty‐eight–joint quantitative articular index in rheumatoid arthritis
Fuchs, H. A., Brooks, R. H., Callahan, L. F., & Pincus, T. (1989) · Arthritis & Rheumatism · doi:10.1002/anr.1780320504 · Cited by 269
Xu, W. D., Firestein, G. S., Taetle, R., Kaushansky, K., & Zvaifler, N. J. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113971 · Cited by 258
Deleuran, B. W., Chu, C., Field, M., Brennan, F. M., Mitchell, T., Feldmann, M., & Maini, R. N. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780351009 · Cited by 217
Self-citationCytokine production in the rheumatoid joint: implications for treatment.
Feldmann, M., Brennan, F. M., Chantry, D., Haworth, C., Turner, M., Abney, E. R., Buchan, G. S., Barrett, K., Barkley, D., & Chu, A. C. (1990) · PubMed · Cited by 146
Self-citationTHE ASSESSMENT OF DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS USING A MULTIVARIATE ANALYSIS
Mallya, R. K., & MACE, B. E. W. (1981) · Lara D. Veeken · doi:10.1093/rheumatology/20.1.14 · Cited by 136
Transforming growth factor-β1 in rheumatoid synovial membrane and cartilage pannus junction
Chu, C., Field, M., Abney, E. R., Zheng, R., Allard, S. A., Feldmann, M., & Maini, R. N. (1991) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1991.tb02941.x · Cited by 92
Self-citationBrennan, F. M., Gibbons, D. L., Cope, A. P., Feldmann, M., Mitchell, T. J., & Maini, R. N. (1992) · European Journal of Immunology · doi:10.1002/eji.1830220734 · Cited by 91
Self-citationRheumatoid arthritis--its present and future.
Ziff, M. (1990) · PubMed · Cited by 45
Roux-Lombard, P., & Steiner, G. E. (1992) · PubMed · Cited by 22
Cited by
ROLE OF CYTOKINES IN RHEUMATOID ARTHRITIS
Feldmann, M., Brennan, F. M., & Maini, R. N. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.397 · Cited by 2,514
Self-citationThe Biology of Chemokines and their Receptors
Rossi, D., & Zlotnik, A. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.217 · Cited by 2,410
Maini, R., St Clair, E. W., Breedveld, F., Furst, D., Kalden, J., Weisman, M., Smolen, J., Emery, P., Harriman, G., Feldmann, M., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(99)05246-0 · Cited by 2,345
Self-citationFishman, D., Faulds, G., Jeffery, R., Mohamed-Ali, V, Yudkin, J. S., Humphries, S., & Woo, P. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2629 · Cited by 2,243
Wilson, A. G., Symons, J. A., McDowell, T. L., McDevitt, H. O., & Duff, G. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3195 · Cited by 2,218
Metadata
- Authors
- Elliott, M. J., Maini, R. N., Feldmann, M., Long‐Fox, A., Charles, P., Katsikis, P., Brennan, F. M., Walker, J., Bijl, H., Ghrayeb, J., & Woody, J. N.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 1993-12
- Volume
- 36
- Issue
- 12
- Pages
- 1681-1690
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2043287930
- Cited by
- 1,038
- References
- 31
- FWCI
- 47.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.